Form 8-K - Current report:
SEC Accession No. 0000950170-22-018805
Filing Date
2022-09-23
Accepted
2022-09-23 08:59:13
Documents
56
Period of Report
2022-09-23
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K sabs-20220923.htm   iXBRL 8-K 67673
2 EX-99.1 sabs-ex99_1.htm EX-99.1 36190
3 EX-99.2 sabs-ex99_2.htm EX-99.2 23467
4 GRAPHIC img2794599_0.jpg GRAPHIC 10467
5 GRAPHIC img2794599_1.jpg GRAPHIC 10467
6 GRAPHIC sabs-ex99_1s1.jpg GRAPHIC 47059
7 GRAPHIC sabs-ex99_1s2.jpg GRAPHIC 74767
8 GRAPHIC sabs-ex99_1s3.jpg GRAPHIC 75249
9 GRAPHIC sabs-ex99_1s4.jpg GRAPHIC 103720
10 GRAPHIC sabs-ex99_1s5.jpg GRAPHIC 67608
11 GRAPHIC sabs-ex99_1s6.jpg GRAPHIC 70470
12 GRAPHIC sabs-ex99_1s7.jpg GRAPHIC 69561
13 GRAPHIC sabs-ex99_1s8.jpg GRAPHIC 71096
14 GRAPHIC sabs-ex99_1s9.jpg GRAPHIC 76292
15 GRAPHIC sabs-ex99_1s10.jpg GRAPHIC 28162
16 GRAPHIC sabs-ex99_1s11.jpg GRAPHIC 62223
17 GRAPHIC sabs-ex99_1s12.jpg GRAPHIC 60622
18 GRAPHIC sabs-ex99_1s13.jpg GRAPHIC 42140
19 GRAPHIC sabs-ex99_1s14.jpg GRAPHIC 102051
20 GRAPHIC sabs-ex99_1s15.jpg GRAPHIC 64714
21 GRAPHIC sabs-ex99_1s16.jpg GRAPHIC 69836
22 GRAPHIC sabs-ex99_1s17.jpg GRAPHIC 93124
23 GRAPHIC sabs-ex99_1s18.jpg GRAPHIC 50860
24 GRAPHIC sabs-ex99_1s19.jpg GRAPHIC 39486
25 GRAPHIC sabs-ex99_1s20.jpg GRAPHIC 66225
26 GRAPHIC sabs-ex99_1s21.jpg GRAPHIC 62043
27 GRAPHIC sabs-ex99_1s22.jpg GRAPHIC 61251
28 GRAPHIC sabs-ex99_1s23.jpg GRAPHIC 70956
29 GRAPHIC sabs-ex99_1s24.jpg GRAPHIC 75209
30 GRAPHIC sabs-ex99_1s25.jpg GRAPHIC 47493
31 GRAPHIC sabs-ex99_1s26.jpg GRAPHIC 36244
32 GRAPHIC sabs-ex99_1s27.jpg GRAPHIC 54674
33 GRAPHIC sabs-ex99_1s28.jpg GRAPHIC 55693
34 GRAPHIC sabs-ex99_1s29.jpg GRAPHIC 62683
35 GRAPHIC sabs-ex99_1s30.jpg GRAPHIC 77970
36 GRAPHIC sabs-ex99_1s31.jpg GRAPHIC 69084
37 GRAPHIC sabs-ex99_1s32.jpg GRAPHIC 86921
38 GRAPHIC sabs-ex99_1s33.jpg GRAPHIC 53408
39 GRAPHIC sabs-ex99_1s34.jpg GRAPHIC 83781
40 GRAPHIC sabs-ex99_1s35.jpg GRAPHIC 28990
41 GRAPHIC sabs-ex99_1s36.jpg GRAPHIC 76687
42 GRAPHIC sabs-ex99_1s37.jpg GRAPHIC 56695
43 GRAPHIC sabs-ex99_1s38.jpg GRAPHIC 95955
44 GRAPHIC sabs-ex99_1s39.jpg GRAPHIC 84251
  Complete submission text file 0000950170-22-018805.txt   3881551

Data Files

Seq Description Document Type Size
45 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT sabs-20220923.xsd EX-101.SCH 3214
46 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT sabs-20220923_def.xml EX-101.DEF 13467
47 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT sabs-20220923_lab.xml EX-101.LAB 17250
48 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT sabs-20220923_pre.xml EX-101.PRE 12759
50 EXTRACTED XBRL INSTANCE DOCUMENT sabs-20220923_htm.xml XML 6479
Mailing Address 2100 EAST 54TH STREET NORTH SIOUX FALLS SD 57104
Business Address 2100 EAST 54TH STREET NORTH SIOUX FALLS SD 57104 605-679-6980
SAB Biotherapeutics, Inc. (Filer) CIK: 0001833214 (see all company filings)

EIN.: 853899721 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39871 | Film No.: 221260692
SIC: 2836 Biological Products, (No Diagnostic Substances)